Document text
cdc.gov/coronavirus
ACIP COVID -19 Vaccines Work Group
Dr. Matthew F. Daley, Work Group Chair
April 19, 2023
▪April 18, 2023: FDA1updated COVID -19 vaccine emergency use authorizations
(EUAs):
–Use of bivalent mRNA vaccines for all doses/indications administered to individuals
ages 6 months and older
–Additional dose(s) for certain populationsCOVID -19 vaccine update:
FDA authorizations
21. https://www.fda.gov/news -events/press -announcements/coronavirus -covid -19-update -fda-authorizes -changes -simplify -use-bivalent -mrna-covid -19-vaccines
▪Review of pediatric COVID -19 vaccine data
▪Epidemiology of COVID -19, including among adults ≥65 years of age
▪Vaccine effectiveness (VE) updates
▪Preliminary results for pediatric cost effectiveness analyses
▪Discussions for additional doses in vulnerable populationsACIP COVID -19 Work Group Meeting Review
March –April 2023
3
▪Vaccine safety updates
▪Vaccine effectiveness data updates
▪Epidemiology and hospitalization data
▪Benefit -risk analysis
▪Considerations for transition to bivalent primary series
▪Future directions of COVID -19 vaccines, including updates to vaccine policyFebruary ACIP COVID -19 Meeting Review
February 24, 2023
4
▪COVID -19 vaccine program updates Dr. Peacock (CDC)
▪COVID -19 vaccine safety updates Dr. Shimabukuro (CDC)
▪Update: v -safe after vaccination health checker Dr. Shimabukuro (CDC)
▪Updates to COVID -19 vaccine effectiveness in the US Dr. Link -Gelles (CDC)
▪Updates to COVID -19 vaccine policy:
Data and Work Group considerations Dr. Oliver (CDC)
▪Updates to Interim Clinical Considerations Dr. Twentyman (CDC)
Break
▪Public Comment
▪DiscussionAgenda:
Wednesday April 19, 2023
ACIP members
▪Matthew Daley (chair)
▪Beth Bell
▪Grace Lee
▪Keipp Talbot
▪Oliver Brooks
Ex-officio/government members
▪FDA: Rachel Zhang, Lucia Lee, Anuja Rastogi
▪NIH: Chris Roberts
▪IHS: Uzo Chukwuma
▪CMS: Jeff Kelman
▪BARDA: Christine Oshansky
▪HHS: David Kim
▪CDC: Alan Lam
CDC Leads
▪Sara Oliver
▪Evelyn TwentymanWork Group members
6Liaisons
▪AAFP: Jonathan Temte
▪AAP: Sean O’Leary
▪ACOG: Denise Jamieson (primary),
Laura Riley (alternate)
▪ACP: Jason Goldman
▪ADS: Emily Kahn
▪AGS: Ken Schmader
▪AIM: Rob Shechter (primary),
Jane Zucker (alternate)
▪AMA: Sandra Fryhofer
▪ANA: Ruth Francis (alternate)
▪APhA: Michael Hogue
▪ASTHO: Marcus Plescia
▪CSTE: Paul Cieslak, Christine Hahn
IDSA: Jeff Duchin (primary)Liaisons, cont’d
▪NACCHO: Matt Zahn (primary),
Jeff Duchin (alternate)
▪NACI: Matthew Tunis (primary),
Nicole Forbes (alternate)
▪NFID: Bill Schaffner (primary),
Marla Dalton (alternate)
▪NMA: Patricia Whitley -Williams
▪SHEA: Preeti Mehrotra
Marci Drees (alternate)
Consultants
▪Ed Belongia
▪Kathy Kinlaw
▪Dayna Matthew
▪Kathleen Neuzil
▪Stanley Perlman
▪Peter Szilagyi
▪Hank Bernstein
▪Sarah Meyer
▪Elisha Hall
▪Megan Wallace
▪Danielle Moulia
▪Lauren Roper
▪Hannah Rosenblum
▪Katherine Fleming -Dutra
▪Monica Godfrey
▪Susan Goldstein
▪Mary Chamberland
▪Stephen Hadler
▪JoEllen Wolicki
▪Melinda Wharton
▪Jessica MacNeil
▪Amanda CohnCDC participants
7▪Ruth Link -Gelles
▪Amadea Britton
▪Carolyn Bridges
▪Allison Ciesla
▪Nicole Dowling
▪Ashley Fowlkes
▪Heather Scobie
▪Natalie Thornburg
▪Tom Shimabukuro
▪John Su
▪Julianne Gee
▪Karen Broder
▪Rita Helfand
▪Jefferson Jones
▪Yvonne Bolen▪Pragna Patel
▪Amanda Payne
▪Georgina Peacock
▪Jose Romero
▪Laura Steinhardt
▪Ryan Wiegand
▪Patricia Yu
▪Yon Yu▪Samuel Graitcer
▪Lisa Grohskopf
▪Katherina Grusich
▪Aaron Hall
▪Terri Hyde
▪Cynthia Jorgensen
▪Kristen Nordlund
▪Sierra Scarbrough
▪Edwin Shanley
▪Andrew Kroger
▪Lauri Markowitz
▪Noelle -Angelique Molinari
▪Michael McNeil
▪Morgan Najdowski
▪Ismael Ortega -Sanchez
For more information, contact CDC
1-800-CDC-INFO (232 -4636)
TTY: 1 -888-232-6348 www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the
official position of the Centers for Disease Control and Prevention.
Thank you!